Michael Klichinsky

This profile gathers the share dealings of Michael Klichinsky in Sesen Bio, Inc., where the filings describe the role as senior executive. We count 3 filings; the first trade dates from 7 March 2023 and the latest from 7 October 2025.

No open-market purchase appears, only 1 sale. The amount is not disclosed for 1 filing. Other entries cover 1 share grant and 1 option exercise. So far in 2025, the count stands at no purchases and 1 sale.

The latest filing, published on 8 October 2025, reports an option exercise in Sesen Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.